• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 42 of 100
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
Finance
Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value
By James Paton and BloombergDecember 9, 2019
Sanofi’s New CEO Readies Rx Plan For Pharma Giant
Leadership
Sanofi’s New CEO Readies Rx Plan For Pharma Giant
By Susie GharibDecember 9, 2019
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
Leadership
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
By Susie GharibDecember 6, 2019
Biogen Alzheimers Drug Data
Newsletters
The Broader Implications of Biogen’s Divisive Alzheimer’s Drug
By Sy MukherjeeDecember 5, 2019
Diabetes medicine pills
Health
FDA Is Testing Diabetes Drug Metformin for NDMA, a Carcinogen
By John Lauerman and BloombergDecember 4, 2019
Astellas Gene Therapy Deal
Newsletters
The Gene Therapy Spree Rolls on With $3 Billion Astellas Deal
By Sy MukherjeeDecember 3, 2019
Biogen Stock Alzheimer's Aducanumab
Newsletters
Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet
By Sy MukherjeeDecember 2, 2019
A boy suffering from dengue fever rests under a mosquito net in a gymnasium
Magazine
Epidemic of fear: How the trouble-ridden debut of a breakthrough vaccine sparked a panic
By Erika FryNovember 26, 2019
Novartis Amarin Cholesterol Drugs
Newsletters
Novartis’ $9.7 Billion Deal Sets off Heart Drug Wars
By Sy MukherjeeNovember 25, 2019
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Fortune Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
Finance
Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.
By James Paton and BloombergNovember 25, 2019
Best Drugs Last 10 Years
Newsletters
Which Medicines Have Transformed Drug Development in the Past Decade?
By Sy MukherjeeNovember 22, 2019
Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
Politics
Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
By Matthew Perrone and The Associated PressNovember 15, 2019
BeiGene FDA Approval Cancer
Newsletters
Chinese Biotech BeiGene Makes a Splash in Cancer Treatment With FDA Drug Approval
By Sy MukherjeeNovember 14, 2019
CRISPR Gene Editing Cancer Safety
Newsletters
CRISPR Gene-Editing Is Being Used to Fight Cancer—And May Be Safe
By Sy MukherjeeNovember 7, 2019
Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
Politics
Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
By Ricardo Alonso-Zaldivar and The Associated PressNovember 5, 2019
1...
  • 40
  • 41
  • 42
  • 43
  • 44
...100
Most Popular
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Middle East
China suffers another setback in effort to de-dollarize global finance as anchor in the greenback's dominance quietly exits Beijing's payment schemeplaceholder alt text
By Jason MaSeptember 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.